✉news HealthNutrition first seen 6 h ago, last 31 min ago, peak #20
Bioiberica Targets Longevity and GLP-1 Ahead of CPHI Milan 2026
Original: CPHI Milan 2026: Bioiberica eyes longevity and GLP-1 as healthy aging becomes targeted
Spanish ingredient manufacturer Bioiberica says it will focus on longevity science and GLP-1-related solutions at CPHI Milan 2026, reflecting the industry's shift toward targeted healthy-aging products. The company is positioning its portfolio around consumers seeking to maintain muscle, joint and metabolic health as they age, while also addressing nutritional support for people using GLP-1 weight-loss medications.
Why now: Healthy aging and GLP-1 companion nutrition are among the fastest-growing trends in the supplement and pharmaceutical ingredient industry
Rank over time, top of the chart is #1. 5 snapshots from 6 h ago to 31 min ago.
Evidence
- CPHI Milan 2026: Bioiberica eyes longevity and GLP-1 as healthy aging becomes targeted · Nutrition Insight
- CPHI Milan 2026: Bioiberica eyes longevity and GLP-1 as healthy aging becomes targeted · Nutrition Insight
API: https://socialmediatrends-api.osmike.com/v1/trends/1238301